Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 571 AL 585

Is Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound a Repeatable Treatment Option? Case Report of a Retreated Patient With Tremor Combined With Parkinsonism

Valentino F, Cosentino G, Maugeri R, Giammalva R, Iacopino GD, Marrale M, Bartolotta TV, Gagliardo C.

Oper Neurosurg. 2020 Jun 1;18(6):577-582. doi: 10.1093/ons/opz300.

Risk of Developing Parkinson Disease in Bipolar Disorder: A Systematic Review and Meta-analysis

Faustino PR, Duarte GS, Chendo I, Castro Caldas A, Reimão S, Fernandes RM, Vale J, Tinazzi M, Bhatia K, Ferreira JJ.

JAMA Neurol. 2020 Feb 1;77(2):192-198. doi: 10.1001/jamaneurol.2019.3446.

The Effects of Computer-Based Cognitive Rehabilitation on Working Memory in Patients with Parkinson's Disease: A Systematic Review

Svaerke K, Niemeijer M, Løkkegaard A.

J Parkinsons Dis. 2020;10(1):47-57. doi: 10.3233/JPD-191726.

Delayed Clinical Manifestation of Parkinson's Disease Among Physically Active: Do Participants in a Long-Distance Ski Race Have a Motor Reserve?

Olsson TT, Svensson M, Hållmarker U, James S, Deierborg T.

J Parkinsons Dis. 2020;10(1):267-274. doi: 10.3233/JPD-191762.

Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework

Matar E, Shine JM, Halliday GM, Lewis SJG.

Brain. 2020 Jan 1;143(1):31-46. doi: 10.1093/brain/awz311.

Drug Choices and Advancements for Managing Depression in Parkinson's Disease

Assogna F, Pellicano C, Savini C, Macchiusi L, Pellicano GR, Alborghetti M, Caltagirone C, Spalletta G, Pontieri FE.

Curr Neuropharmacol. 2020;18(4):277-287. doi: 10.2174/1570159X17666191016094857.

Plant Polyphenols as Neuroprotective Agents in Parkinson's Disease Targeting Oxidative Stress

Hor SL, Teoh SL, Lim WL.

Curr Drug Targets. 2020;21(5):458-476. doi: 10.2174/1389450120666191017120505.

Multicenter Alzheimer's and Parkinson's disease immune biomarker verification study

Brosseron F, Kolbe CC, Santarelli F, Carvalho S, Antonell A, Castro-Gomez S, Tacik P, Namasivayam AA, Mangone G, Schneider R, Latz E, Wüllner U, Svenningsson P, Sánchez-Valle R, Molinuevo JL, Corvol JC, Heneka MT; AETIONOMY study group.

Alzheimers Dement. 2020 Feb;16(2):292-304. doi: 10.1016/j.jalz.2019.07.018. Epub 2020 Jan 6.

A Role for SERCA Pumps in the Neurobiology of Neuropsychiatric and Neurodegenerative Disorders

Britzolaki A, Saurine J, Klocke B, Pitychoutis PM.

Adv Exp Med Biol. 2020;1131:131-161. doi: 10.1007/978-3-030-12457-1_6.

Freezing of gait: understanding the complexity of an enigmatic phenomenon

Weiss D, Schoellmann A, Fox MD, Bohnen NI, Factor SA, Nieuwboer A, Hallett M, Lewis SJG.

Brain. 2020 Jan 1;143(1):14-30. doi: 10.1093/brain/awz314.

Managing Parkinson's disease: moving ON with NOP

Mercatelli D, Bezard E, Eleopra R, Zaveri NT, Morari M.

Br J Pharmacol. 2020 Jan;177(1):28-47. doi: 10.1111/bph.14893. Epub 2020 Jan 3.

Motor Function Improvement After Electroconvulsive Therapy in a Parkinson's Disease Patient With Deep Brain Stimulator

Volkaerts L, Roels R, Bouckaert F.

J ECT. 2020 Mar;36(1):66-68. doi: 10.1097/YCT.0000000000000627.

Biomarkers in Tears and Ocular Surface: A Window for Neurodegenerative Diseases

Roda M, Ciavarella C, Giannaccare G, Versura P.

Eye Contact Lens. 2020 Mar;46 Suppl 2:S129-S134. doi: 10.1097/ICL.0000000000000663.

Motor Disturbance in ASD: A Pilot Study Showing Hypokinetic Behavior?

Mostert-Kerckhoffs MAL, Willems AE, Tenback DE, Koning JP, Van Harten P, Staal WG.

J Autism Dev Disord. 2020 Feb;50(2):415-428. doi: 10.1007/s10803-019-04171-1.

DNA damage and repair in neuropsychiatric disorders. What do we know and what are the future perspectives?

Czarny P, Bialek K, Ziolkowska S, Strycharz J, Sliwinski T.

Mutagenesis. 2020 Feb 13;35(1):79-106. doi: 10.1093/mutage/gez035.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias